Teserpaturev

N/A

Report date: 2022/07/08 16:09:08

Base Information

Drug NameTeserpaturev
Drug Alias NameG47 delta oncolytic virus therapyDelytactDS-1647G47-deltaG47δ
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionImmunomodulatorsGene transference
TargetsNot applicable
Therapy Area/IndicationsGlioma
Global Approved IndicationsGlioma
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2021/06/11
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesUniversity Of TokyoDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDaiichi Sankyo Co Ltd
Inactive CompaniesN/A
Active IndicationsGlioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A